Moolec Science SA (NASDAQ:MLEC) Short Interest Down 48.9% in July

Moolec Science SA (NASDAQ:MLEC) was the recipient of a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 9,414 shares, a decrease of 48.9% from the June 30th total of 18,435 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average trading volume of 4,381 shares, the days-to-cover ratio is presently 2.1 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in Moolec Science SA (NASDAQ:MLEC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science at the end of the most recent quarter. Institutional investors own 0.07% of the company’s stock.

Moolec Science Price Performance

NASDAQ MLEC traded down $0.04 on Wednesday, hitting $7.22. 2,008 shares of the company’s stock were exchanged, compared to its average volume of 698,886. The stock has a 50-day moving average of $7.50 and a 200-day moving average of $8.01. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79. Moolec Science has a 52 week low of $3.08 and a 52 week high of $53.40. The stock has a market cap of $5.24 million, a price-to-earnings ratio of -0.22 and a beta of 0.26.

Moolec Science (NASDAQ:MLEC) last issued its quarterly earnings results on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The business had revenue of $2.62 million during the quarter.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.